IL145263A0 - Controlled-release compositions of betahistine - Google Patents

Controlled-release compositions of betahistine

Info

Publication number
IL145263A0
IL145263A0 IL14526300A IL14526300A IL145263A0 IL 145263 A0 IL145263 A0 IL 145263A0 IL 14526300 A IL14526300 A IL 14526300A IL 14526300 A IL14526300 A IL 14526300A IL 145263 A0 IL145263 A0 IL 145263A0
Authority
IL
Israel
Prior art keywords
betahistine
controlled
release compositions
compositions
release
Prior art date
Application number
IL14526300A
Other languages
English (en)
Original Assignee
Formenti Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Formenti Farmaceutici Spa filed Critical Formenti Farmaceutici Spa
Publication of IL145263A0 publication Critical patent/IL145263A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Otolaryngology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Steroid Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL14526300A 1999-03-05 2000-02-28 Controlled-release compositions of betahistine IL145263A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI000454A IT1309591B1 (it) 1999-03-05 1999-03-05 Composizioni a rilascio controllato di betaistina.
PCT/EP2000/001642 WO2000053162A1 (en) 1999-03-05 2000-02-28 Controlled-release compositions of betahistine

Publications (1)

Publication Number Publication Date
IL145263A0 true IL145263A0 (en) 2002-06-30

Family

ID=11382165

Family Applications (1)

Application Number Title Priority Date Filing Date
IL14526300A IL145263A0 (en) 1999-03-05 2000-02-28 Controlled-release compositions of betahistine

Country Status (37)

Country Link
EP (1) EP1158963B1 (da)
JP (1) JP2002538197A (da)
KR (1) KR20010102498A (da)
CN (1) CN1165295C (da)
AR (1) AR029154A1 (da)
AT (1) ATE231392T1 (da)
AU (1) AU762532B2 (da)
BG (1) BG105807A (da)
BR (1) BR0008739A (da)
CA (1) CA2364226A1 (da)
CO (1) CO5170438A1 (da)
CZ (1) CZ299510B6 (da)
DE (1) DE60001266T2 (da)
DK (1) DK1158963T3 (da)
EE (1) EE200100453A (da)
ES (1) ES2189739T3 (da)
GE (1) GEP20033078B (da)
HK (1) HK1042246B (da)
HR (1) HRP20010650A2 (da)
HU (1) HUP0200243A2 (da)
ID (1) ID30127A (da)
IL (1) IL145263A0 (da)
IT (1) IT1309591B1 (da)
MX (1) MXPA01008893A (da)
NO (1) NO319135B1 (da)
NZ (1) NZ513949A (da)
PE (1) PE20001547A1 (da)
PL (1) PL196290B1 (da)
PT (1) PT1158963E (da)
RU (1) RU2248791C2 (da)
SI (1) SI1158963T1 (da)
SK (1) SK284584B6 (da)
TR (1) TR200102566T2 (da)
UA (1) UA65652C2 (da)
WO (1) WO2000053162A1 (da)
YU (1) YU64001A (da)
ZA (1) ZA200107318B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004064807A1 (en) * 2003-01-23 2004-08-05 Amorepacific Corporation Sustained-release preparations and method for producing the same
SI1493435T1 (sl) 2003-07-04 2008-10-31 Formenti Farmaceutici Spa Betahistinski sestavki s kontroliranim sproĺ äśanjem
US7728015B2 (en) 2004-04-22 2010-06-01 Mor Research Applications Ltd. Compositions for weight management
BRPI0506807A (pt) 2004-04-22 2007-05-29 Mor Research Applic Ltd método de gerenciamento de consumo de alimento e composição farmacológica
WO2006009403A1 (en) * 2004-07-22 2006-01-26 Amorepacific Corporation Sustained-release preparations containing topiramate and the producing method thereof
JP2006176461A (ja) * 2004-12-24 2006-07-06 Dai Ichi Seiyaku Co Ltd 粒状物
AU2009253739B2 (en) 2008-05-27 2014-02-06 Otolanum Ag Methods of treating mammals with eustachian tube dysfunctions
EP2314296A1 (en) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Orally Disintegrating Tablets of Betahistine
EP2491930A1 (en) * 2011-02-25 2012-08-29 Deva Holding Anonim Sirketi Pharmaceutical combination of betahistine and trimetazidine
DE102012105528A1 (de) 2012-06-25 2014-01-02 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur Freisetzung von Wirkstoffen
WO2015053620A1 (en) * 2013-10-07 2015-04-16 Disphar International B.V. Betahistine composition
DK3431078T3 (da) * 2017-07-20 2021-04-19 Intas Pharmaceuticals Ltd Orale faste betahistinsammensætninger med ikkepulserende forlænget frigivelse

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2432313A1 (fr) * 1978-08-01 1980-02-29 Foulhoux Pierre Nouvelle forme galenique de la betahistine et son procede d'obtention
GB2280604B (en) * 1993-07-02 1997-04-30 Resource Medical Limited Processing of active agents
PL191399B1 (pl) * 1996-10-28 2006-05-31 Gen Mills Inc Sposób kapsułkowania lub osadzania składnika w osnowie w procesie ciągłym, sposób kapsułkowania i/lub osadzania składników w osnowie opartej na węglowodanach, sposób kapsułkowania i/lub osadzania składników w osnowie oraz kapsułka

Also Published As

Publication number Publication date
AU762532B2 (en) 2003-06-26
PL350232A1 (en) 2002-11-18
NO20014301D0 (no) 2001-09-04
ITMI990454A1 (it) 2000-09-05
RU2248791C2 (ru) 2005-03-27
CO5170438A1 (es) 2002-06-27
CN1342069A (zh) 2002-03-27
CA2364226A1 (en) 2000-09-14
DE60001266D1 (de) 2003-02-27
UA65652C2 (uk) 2004-04-15
HK1042246B (zh) 2005-06-03
KR20010102498A (ko) 2001-11-15
BR0008739A (pt) 2001-12-26
EP1158963A1 (en) 2001-12-05
HUP0200243A2 (en) 2002-06-29
JP2002538197A (ja) 2002-11-12
ATE231392T1 (de) 2003-02-15
SK12492001A3 (sk) 2001-12-03
ZA200107318B (en) 2002-09-04
YU64001A (sh) 2004-05-12
AU3283100A (en) 2000-09-28
EE200100453A (et) 2002-12-16
IT1309591B1 (it) 2002-01-24
HK1042246A1 (en) 2002-08-09
ES2189739T3 (es) 2003-07-16
HRP20010650A2 (en) 2002-10-31
TR200102566T2 (tr) 2002-01-21
BG105807A (bg) 2002-03-29
CN1165295C (zh) 2004-09-08
AR029154A1 (es) 2003-06-18
CZ299510B6 (cs) 2008-08-20
DK1158963T3 (da) 2003-04-28
DE60001266T2 (de) 2003-08-28
MXPA01008893A (es) 2002-10-23
PT1158963E (pt) 2003-06-30
CZ20013186A3 (cs) 2002-02-13
NO20014301L (no) 2001-09-04
PL196290B1 (pl) 2007-12-31
SK284584B6 (sk) 2005-07-01
NO319135B1 (no) 2005-06-20
ID30127A (id) 2001-11-08
PE20001547A1 (es) 2001-01-29
WO2000053162A1 (en) 2000-09-14
SI1158963T1 (en) 2003-04-30
NZ513949A (en) 2003-10-31
GEP20033078B (en) 2003-10-27
EP1158963B1 (en) 2003-01-22

Similar Documents

Publication Publication Date Title
AU6103200A (en) Perfume compositions
GB9918180D0 (en) Novel compositions
GB9921037D0 (en) Compositions
IL145263A0 (en) Controlled-release compositions of betahistine
EG22530A (en) Preparation of substituted piperidin-4-ones
GB9904049D0 (en) Rapidly-soluble compositions
EP1218407A4 (en) USES OF KAPPA-CONOTOXIN PVIIA
EP1208268A4 (en) NOVEL QUATERNARY COMPOUNDS, COMPOSITIONS CONTAINING THESE COMPOUNDS AND CORRESPONDING USES THEREOF
IL144693A0 (en) Preparation of carvone
GB9923882D0 (en) Chemical composition
IL130325A0 (en) Pharmaceutical compositions comprising allicin
GB9929622D0 (en) Compositions
GB9903924D0 (en) Cosmectic compositions
GB9926833D0 (en) Compositions
GB9923353D0 (en) Chemical composition
GB9912409D0 (en) Compounds and compositions
PL333214A1 (en) Multiple-purpose piece of furniture
PL109202U1 (en) Multiple-purpose piece of furniture
GB9912373D0 (en) Powder composition
GB9909079D0 (en) Novel formulations
GB9909080D0 (en) Novel formulations
PL337598A1 (en) Novel compound - derivative of (r)-3-hydroxynonanal
HU9900075V0 (en) Sepulchre consists of elements
GB0029455D0 (en) Novel compositions
GB9929188D0 (en) Chemical composition